Clinical Trial Update: Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial of a fractional-dose tetravalent meningococcal polysaccharide vaccine (serogroups A, C, Y, W135) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infections
• Meningococcal Meningitis

Drugs mentioned

• Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine (Meningococcal polysaccharide vaccine (A, C, Y, W135), fractional dose)

Snippet

Sponsor: Epicentre | Conditions: Infections, Meningococcal, Meningitis, Meningococcic | Phase 4 | Status: COMPLETED